Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
10.63
-0.49 (-4.41%)
At close: Dec 24, 2024, 4:00 PM
11.16
+0.53 (4.99%)
After-hours: Dec 24, 2024, 4:17 PM EST

Neumora Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
124
Market Cap
1.72B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
GoodRx Holdings 790.39M
Amphastar Pharmaceuticals 723.55M
10x Genomics 629.74M
Certara 372.80M
Galapagos NV 290.09M
MannKind 267.20M
Arcutis Biotherapeutics 138.71M
ImmunityBio 7.33M
Revenue Rankings